Henry Schein, Inc.  

(Public, NASDAQ:HSIC)   Watch this stock  
Find more results for hsic
-1.62 (-2.34%)
After Hours: 67.65 +0.15 (0.22%)
Nov 20, 4:21PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 66.13 - 69.26
52 week 65.28 - 93.50
Open 68.87
Vol / Avg. 2.75M/2.43M
Mkt cap 10.59B
P/E 19.43
Div/yield     -
EPS 3.47
Shares 156.95M
Beta 1.03
Inst. own 95%
Nov 28, 2017
Henry Schein Inc at Piper Jaffray Healthcare Conference - 9:00AM EST - Add to calendar
Nov 7, 2017
Henry Schein Inc at Credit Suisse Healthcare Conference - Webcast
Nov 6, 2017
Q3 2017 Henry Schein Inc Earnings Call - Webcast
Nov 6, 2017
Q3 2017 Henry Schein Inc Earnings Release
Sep 11, 2017
Henry Schein Inc at Morgan Stanley Healthcare Conference - Webcast
Sep 6, 2017
Henry Schein Inc at Robert W Baird Gobal Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 4.60% 4.65%
Operating margin 6.76% 6.67%
EBITD margin - 8.53%
Return on average assets 8.00% 8.13%
Return on average equity 18.65% 17.85%
Employees 21,000 -
CDP Score - -


135 Duryea Rd
United States - Map
+1-631-8435500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. The Company provides its services to dental practitioners and laboratories, animal health clinics and physician practices, as well as government and institutional healthcare clinics.

Officers and directors

Stanley M. Bergman Chairman of the Board, Chief Executive Officer
Age: 67
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James P. Breslawski CPA President, Director; Chief Executive Officer of Henry Schein Global Dental Group
Age: 63
Bio & Compensation  - Reuters
Steven Paladino CPA Chief Financial Officer, Executive Vice President, Director
Age: 59
Bio & Compensation  - Reuters
Peter McCarthy President of Global Animal Health Group
Age: 57
Bio & Compensation  - Reuters
David C. McKinley President of Corporate Commercial Development Group, Chief Commercial Officer
Age: 64
Bio & Compensation  - Reuters
Bob Minowitz President, International Dental Group, EMEA Region
Age: 58
Bio & Compensation  - Reuters
Bridget A. Ross President of Global Medical Group
Age: 52
Bio & Compensation  - Reuters
Gerald A. Benjamin Chief Administrative Officer, Executive Vice President, Director
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark E. Mlotek Chief Strategic Officer, Executive Vice President, Director
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Karen N. Prange Executive Vice President; Chief Executive Officer of Global Animal Health, Medical and Dental Surgical Group
Age: 53
Bio & Compensation  - Reuters